SCARONI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.094
AS - Asia 6.642
EU - Europa 4.924
SA - Sud America 1.490
AF - Africa 1.332
OC - Oceania 153
Continente sconosciuto - Info sul continente non disponibili 61
AN - Antartide 1
Totale 33.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.347
SG - Singapore 2.080
CN - Cina 1.465
HK - Hong Kong 1.064
BR - Brasile 1.027
IT - Italia 1.027
DE - Germania 560
VN - Vietnam 557
FI - Finlandia 426
SE - Svezia 334
PL - Polonia 299
GB - Regno Unito 260
RU - Federazione Russa 233
FR - Francia 226
UA - Ucraina 218
NL - Olanda 181
KR - Corea 150
IN - India 115
AT - Austria 114
IE - Irlanda 97
TR - Turchia 94
MX - Messico 87
CI - Costa d'Avorio 84
AR - Argentina 68
CA - Canada 67
EC - Ecuador 67
ZA - Sudafrica 60
ES - Italia 58
IQ - Iraq 57
JP - Giappone 56
MA - Marocco 56
CL - Cile 55
PE - Perù 52
AE - Emirati Arabi Uniti 47
CO - Colombia 47
HU - Ungheria 47
ID - Indonesia 47
CH - Svizzera 45
AL - Albania 44
DO - Repubblica Dominicana 44
KE - Kenya 44
ME - Montenegro 44
AO - Angola 42
BE - Belgio 42
NZ - Nuova Zelanda 42
PK - Pakistan 42
TH - Thailandia 42
GT - Guatemala 41
HN - Honduras 41
LU - Lussemburgo 41
PS - Palestinian Territory 41
BY - Bielorussia 40
NO - Norvegia 40
PY - Paraguay 40
UY - Uruguay 40
DJ - Gibuti 39
IL - Israele 39
KG - Kirghizistan 39
LC - Santa Lucia 39
SA - Arabia Saudita 39
SO - Somalia 39
GR - Grecia 38
LA - Repubblica Popolare Democratica del Laos 38
LB - Libano 38
PH - Filippine 38
VE - Venezuela 38
BF - Burkina Faso 37
BJ - Benin 37
BS - Bahamas 37
BZ - Belize 37
GH - Ghana 37
NE - Niger 37
BB - Barbados 36
JO - Giordania 36
KH - Cambogia 36
NC - Nuova Caledonia 36
AM - Armenia 35
CR - Costa Rica 35
EE - Estonia 35
HR - Croazia 35
IS - Islanda 35
SK - Slovacchia (Repubblica Slovacca) 35
TN - Tunisia 35
AZ - Azerbaigian 34
CZ - Repubblica Ceca 34
GE - Georgia 34
MD - Moldavia 34
MY - Malesia 34
NI - Nicaragua 34
PA - Panama 34
PT - Portogallo 34
SN - Senegal 34
UG - Uganda 34
JM - Giamaica 33
MK - Macedonia 33
BD - Bangladesh 32
CV - Capo Verde 32
EG - Egitto 32
ML - Mali 32
MR - Mauritania 32
Totale 32.185
Salva come PNG Salva come JPEG
Città #
Fairfield 2.689
Ashburn 1.739
Woodbridge 1.648
Chandler 1.388
Singapore 1.301
Houston 1.245
Ann Arbor 1.098
Hong Kong 1.017
Cambridge 987
Seattle 980
Wilmington 866
Jacksonville 705
Boardman 438
Beijing 437
Santa Clara 389
Princeton 373
Dong Ket 344
Padova 271
San Diego 267
Bytom 228
Medford 215
Helsinki 184
Des Moines 181
Roxbury 157
Hefei 153
Munich 145
Nanjing 136
Los Angeles 126
Milan 117
Seoul 110
New York 87
São Paulo 86
Ho Chi Minh City 80
Abidjan 78
Dublin 76
Nuremberg 64
Buffalo 61
London 55
Vienna 55
Hanoi 52
Shenyang 45
Frankfurt am Main 41
Luanda 40
Rio de Janeiro 40
Turku 40
Castries 39
Redondo Beach 39
Brooklyn 38
Djibouti 38
Nanchang 38
Guangzhou 36
Nairobi 36
Nassau 36
Noumea 36
Hebei 35
Podgorica 35
Amman 34
Cotonou 34
Dakar 34
Kampala 34
Norwalk 34
Panama City 34
Rome 34
Villafranca Padovana 34
Managua 33
Accra 32
Bishkek 32
Nouakchott 32
Phnom Penh 32
Warsaw 32
Bridgetown 31
Vientiane 31
Baku 30
Bamako 30
Falls Church 30
Istanbul 30
Montevideo 30
Ouagadougou 30
Ulan Bator 30
Auckland 29
Changsha 29
Niamey 29
San Francisco 29
Chicago 28
Lima 28
Lusaka 28
Tallinn 28
Guayaquil 27
Athens 26
Belize City 26
Jiaxing 26
Jinan 26
Johannesburg 26
Minsk 26
Reykjavik 26
San José 26
Tashkent 26
Tbilisi 26
Willemstad 26
Antananarivo 25
Totale 22.543
Salva come PNG Salva come JPEG
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 268
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 242
Paradoxical GH increase during OGTT is associated to first-generation somatostatin analogs responsiveness in acromegaly 232
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 209
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 206
Diagnosis and complications of Cushing's disease: gender-related differences. 204
Letter to Editor: Reply to R.T. Casey (Semin Oncol. 2018 Jun;45(3):151-155) 196
Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease 192
Improved salivary cortisol rhythm with dual-release hydrocortisone 191
Activation of the Dopamine Receptor Type-2 (DRD2) Promoter by 9-Cis Retinoic Acid in a Cellular Model of Cushing's Disease Mediates the Inhibition of Cell Proliferation and ACTH Secretion Without a Complete Corticotroph-to-Melanotroph Transdifferentiation 183
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 182
Perioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova model 182
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 181
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 180
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 179
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 179
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 179
Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor 179
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 178
Age and the metabolic syndrome affect salivary cortisol rhythm: Data from a community sample 178
Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. 177
Early recognition of aggressive pituitary adenomas: a single-centre experience 176
Metyrapone treatment in Cushing’s syndrome: a real-life study 175
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on "real-world evidence" 175
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 174
Aldosterone in Gynecology and Its Involvement on the Risk of Hypertension in Pregnancy 173
Clinical presentation and management of acromegaly in elderly patients 171
Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: effects of glucocorticoid treatment and surgery 167
A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma 163
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 163
Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up. 162
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 162
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 161
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 161
The Role of Unilateral Adrenalectomy in ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH). 160
Diagnostic performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma and adrenal insufficiency. 160
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor 160
A scoring system increases specificity of I-MIBG scan for the diagnosis of pheochromocytoma 158
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 158
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype 157
Treatment of polycystic ovary syndrome with spironolactone plus licorice. 157
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. 157
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation 157
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 156
Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma 155
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 155
Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole? 154
Analysis of gpr101 and aip genes mutations in acromegaly: a multicentric study. 154
Different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia 154
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 153
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study 153
Intracranial internal carotid artery changes in acromegaly: a quantitative magnetic resonance angiography study. 152
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 152
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors 151
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 150
Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate 148
Low-dose short synacthen test with salivary cortisol in patients with suspected central adrenal insufficiency 148
Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia. 147
Human Corticotropin-Releasing Hormone tests: 10 years of real-life experience in pituitary and adrenal disease 147
New insight into the Hypercoagulability of Cushing's Syndrome 145
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study 143
Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up. 142
New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography 141
Long-Lasting Effects of Spironolactone After its Withdrawal in Patients with Hyperandrogenic Skin Disorders 141
Radiotherapy in acromegaly: Long-term brain parenchymal and vascular magnetic resonance changes 140
Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients 140
Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications 139
A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome 139
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 137
The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome 137
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas. 136
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 135
Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results 134
Gonadotropin secreting pituitary adenoma associated with erythrocytosis: case report and literature review. 134
Cortisol and cortisone ratio in urine: LC-MS/MS method validation and preliminary clinical application. 134
HLA and hormonal studies in 5 patients with late-onset 21-hydroxylase deficiency syndrome (21OHDS). 133
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 133
Therapeutic strategies for Cushing's syndrome: An update 133
Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development and validation 133
Hypercortisolism and pregnancy upregulate von Willebrand factor through different mechanisms: report on a pregnant patient with Cushing's syndrome. 133
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 132
The R304X mutation of the Aryl hydrocarbon receptor Interacting Protein gene in familial isolated pituitary adenomas: mutational Hot-Spot or founder effect? 131
Microsatellite (GT)(n) is part of the von Willebrand factor (VWF) promoter region that influences the glucocorticoid-induced increase in VWF in Cushing's syndrome. 131
Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth? 131
The glucose-dependent insulinotropic polypeptide receptor (GIPR) is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives GH-promoter activity in GH3 cells. 130
Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules 130
A scoring system increases specificity of I-MIBG scan for the diagnosis of pheochromocytoma 129
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. 129
The GIP/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp(-) somatotropinomas 127
Glucose metabolism abnormalities in Cushing's syndrome: from molecular basis to clinical management 126
Body Composition is Different after Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study 126
Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury 125
Volumetric MRI analysis of hippocampal subregions in Cushing’s disease: A model for glucocorticoid neural modulation 124
Licorice reduces serum testosterone in healthy women 124
Increased rate of intracranial saccular aneurysms in acromegaly: an MR angiography study and review of the literature. 124
Effect of short term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerosis markers in hypopituitary patients with growth hormone deficiency. 123
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 123
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 123
Steroids and Hypertension 123
Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man. 122
Totale 15.548
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.847
article - articoli 113.899
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.181
Totale 235.927
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.979 0 0 203 229 112 183 122 273 452 352 393 660
2021/20223.770 128 401 419 273 249 248 178 423 184 98 346 823
2022/20232.764 628 355 37 342 400 351 13 182 282 25 118 31
2023/20241.616 55 201 175 134 157 179 165 98 41 42 162 207
2024/20257.213 35 541 305 307 922 206 397 621 633 288 1.086 1.872
2025/20267.319 1.385 2.563 3.371 0 0 0 0 0 0 0 0 0
Totale 34.187